Recent Finacing
Recent Raise
IRX Therapeutics develops cytokine-based immunotherapies, including IRX-2, that aim to stimulate antitumor and antiviral immune responses and is conducting mid-stage clinical trials in multiple sites.
Focus Areas
Total Raised
Funding round